While most studies have focused on SLC7A11-mediated cystine import, this study suggests that SLC7A11-mediated glutamate export can cross-talk with and modulate tumor immune systems, which in turn influence tumor growth and response to cancer therapies. Here, SLC7A11 is linked to cancer.